Lipid Markers Can Predict Recurrent Infarcts in intracranial atherosclerotic disease

Written By : MD Bureau |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2022-02-15T09:00:10+05:30 | Updated On 15 Feb 2022 9:00 AM IST

Lipid Markers Can Predict Recurrent Infarcts in intracranial atherosclerotic disease

Hyperlipidemia is a strong risk factor for intracranial atherosclerotic disease (ICAD) and clinical stroke recurrence. A recent study suggests that low-density lipoprotein and triglyceride levels at the time of index stroke or transient ischemic attack can predict recurrent infarcts independent of other clinical and imaging factors. The study findings were published in the Journal of Stroke & Cerebrovascular Diseases on October 26, 2021.

ICAD is a common cause of ischemic stroke with a high risk of clinical stroke recurrence. Multiple mechanisms may underlie cerebral ischemia in this condition. Dr Shyam Prabhakaran and his team conducted a study to explore the effect of serum lipid levels on subclinical infarct recurrence in the Mechanisms of earlY Recurrence in Intracranial Atherosclerotic Disease (MYRIAD) study.

In this present study, the researchers included 74 patients from the MYRIAD study with lipid measurements and brain MRI at baseline and brain MRI at 6-8 weeks. They determined infarct recurrence as new infarcts in the territory of the symptomatic artery on brain MRI at 6-8 weeks compared to baseline brain MRI. Using multivariable logistic regression, they assessed the association between baseline total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglyceride (TG) levels and recurrent infarction at 6-8 weeks.

Key findings of the study:

Upon analysis, the researchers observed that the mean HDL-C (37.2 vs 43.9 mg/dL) was lower and TG (113.5 vs 91.3 mg/dL) was higher, while TC (199.8 vs 174.3 mg/dL) and LDL-C (124.3 vs 101.2 mg/dL) were nominally higher among those with recurrent infarcts than those without.
After adjusting for other clinical and imaging factors, they noted that LDL-C (adj. OR 1.022) and TG (adj. OR 1.009) were predictors of recurrent infarct at 6-8 weeks.

The authors concluded, "Baseline cholesterol markers can predict early infarct recurrence in patients with symptomatic ICAD. More intensive and rapid lipid lowering drugs may be required to reduce the risk of early recurrence."

They further added, "More aggressive and rapid reduction of lipid levels may be required to reduce the burden of early clinical and subclinical recurrence in patients with symptomatic intracranial stenosis."

For further information:

DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106141

CholesterolStrokeStatinMagnetic resonance imagingJournal of Stroke & Cerebrovascular Diseases

Article Source : Journal of Stroke & Cerebrovascular Diseases

Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Next Story